3 receptorer, forventes ikke at interferere med DaTSCAN billeddannelse og anvendelsen af disse kan derfor fortsættes, hvis det ønskes.
Dopamine agonists and antagonists acting on the postsynaptic dopamine receptors are not expected to interfere with DaTSCAN imaging and can therefore be continued if desired.